欢迎来到喀斯玛汇智科技服务平台

服务热线: 010-82648522

首页 > 专利推荐 > 专利详情

13,13A-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE

  • 申请号:EP20070816496
  • 专利类型:EP
  • 申请(专利权)人:中国科学院上海药物研究所
  • 公开(公开)号:EP2070926(B1)
  • 公开(公开)日:2011.09.07
  • 法律状态:
  • 出售价格: 面议
  • 立即咨询

专利详情

专利名称 13,13A-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE
申请号 EP20070816496 专利类型 EP
公开(公告)号 EP2070926(B1) 公开(授权)日 2011.09.07
申请(专利权)人 中国科学院上海药物研究所 发明(设计)人 HU, LIHONG;YE, JIMING;LI, JINGYA;JAMES, DAVID, E;KRAEGEN, EDWARD, W;ZHANG, HANKUN;CHENG, ZHE;LI, JIA
主分类号 C07D455/03 IPC主分类号 C07D455/03;A61K31/4375;A61P3/04;A61P3/06;A61P3/10
专利有效期 13,13A-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE 至13,13A-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE 法律状态
说明书摘要 The present invention provides 13,13a-dihydroberberine derivatives or their physiologically acceptable salts represented by the following formula, pharmaceutical compositions comprising the same, and uses thereof. The 13,13a-dihydroberberine derivatives have an activity of promoting glucose absorption in muscle cells, and the whole animal tests show that the present compounds have effects on improving glucose-tolerance and insulin-resistance, facilitating weight loss, relieving fatty liver and the like. Thus, the present compounds can be used in treating diabetes mellitus, adiposity, fatty liver and complications thereof induced by insulin resistance.

交易流程

  • 01 选取所需
    专利
  • 02 确认专利
    可交易
  • 03 签订合同
  • 04 上报材料
  • 05 确认变更
    成功
  • 06 支付尾款
  • 07 交付证书

平台保障

1、源头对接,价格透明

2、平台验证,实名审核

3、合同监控,代办手续

4、专员跟进,交易保障

  • 用户留言
暂时还没有用户留言

求购专利

专利交易流程

  • 01 选取所需专利
  • 02 确认专利可交易
  • 03 签订合同
  • 04 上报材料
  • 05 确认变更成功
  • 06 支付尾款
  • 07 交付证书
官方客服(周一至周五:8:30-17:30) 010-82648522